Randomized Controlled Trial of Icodextrin versus Glucose Containing Peritoneal Dialysis Fluid
- 1 November 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 4 (11), 1799-1804
- https://doi.org/10.2215/cjn.02950509
Abstract
Background and objectives: While peritoneal dialysis with icodextrin is commonly used in patients with poor peritoneal membrane characteristics, the data on the usefulness of this solution in patients with lower transport characteristics are limited. The study was designed to compare icodextrin to glucose in Chinese prevalent peritoneal dialysis patients of different peritoneal transport characteristics (PET) categories. Design, setting, participants, & measurements: This was a randomized, double-blind, perspective control study. Stable prevalent continuous ambulatory peritoneal dialysis (CAPD) patients were randomized to either 7.5% icodextrin (ICO) or 2.5% glucose (GLU) solution for 4 wk. Peritoneal membrane function was measured to define PET category in baseline. Creatinine clearance (Ccr), urea nitrogen clearance (CBUN), ultrafiltration (UF) during the long night dwell, dialysate, and metabolic biomarkers were measured at baseline, 2, and 4 wk. UF, Ccr, and CBUN were compared among different PET categories. Results: A total of 201 CAPD patients were enrolled in the study. There were no baseline differences between the groups. Following 2 and 4 wk of therapy, Ccr, CBUN, and UF were all significantly higher in the ICO versus the GLU group. Additionally, switching to ICO resulted in a significant increase in UF in high, high-average, and low-average transporters as compared with baseline. The extent of increased UF was more obvious in higher transporters. Blood cholesterol level in the ICO group decreased significantly than that in the GLU group. Conclusion: Compared with glucose-based solution, 7.5% icodextrin significantly improved UF and small solute clearance, even in patients with low-average peritoneal transport.Keywords
This publication has 21 references indexed in Scilit:
- Initiation of Glucose-Based Peritoneal Dialysis Is Associated with Increased Prevalence of Metabolic Syndrome in Non-Diabetic Patients with End-Stage Renal DiseaseBlood Purification, 2008
- Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centreNephrology Dialysis Transplantation, 2008
- Effects of Icodextrin on Glycemic and Lipid Profiles in Diabetic Patients Undergoing Peritoneal DialysisAmerican Journal of Nephrology, 2007
- Favorable changes in lipid metabolism and cardiovascular parameters after icodextrin use in peritoneal dialysis patients.2007
- Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patientsNephrology Dialysis Transplantation, 2005
- Genetic and clinical factors influence the baseline permeability of the peritoneal membraneKidney International, 2005
- Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centreNephrology Dialysis Transplantation, 2005
- A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysisAmerican Journal of Kidney Diseases, 2002
- Metabolic and laboratory effects of icodextrinKidney International, 2002
- Comparison of icodextrin and glucose solutions for daytime dwell in automated peritoneal dialysisNephrology Dialysis Transplantation, 1999